Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2020

01.06.2020 | editorial

Epithelial ovarian cancer

verfasst von: M.D. Prof. Alexander Reinthaller

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Epithelial ovarian cancer is the leading cause of death among all gynecologic cancers in developed countries. The estimated number of newly diagnosed ovarian cancers per year in Europe is approximately 66,000 with 43,000 deaths. One of the main factors contributing to the high death-to-incidence rate is the advanced stage of the disease defined by the spread of the disease outside the pelvis at the time of the initial diagnosis. More than two thirds of patients are diagnosed at an advanced stage of the disease. Late-stage presentation has a 5-year survival rate between 30 and 50% depending on the expertise of the treating center. In contrast early stage disease can be cured in 70–90% of individuals. The main reason for the advanced stage presentation is the lack of early symptoms during the development of epithelial ovarian cancer. …
Literatur
Metadaten
Titel
Epithelial ovarian cancer
verfasst von
M.D. Prof. Alexander Reinthaller
Publikationsdatum
01.06.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00608-x